Study organization
The clinical trial is being performed in 32 reference hospitals
in Spain (16 centers), Greece (10 centers) and Italy (6 centers). The coordinating trial site is located in the same public hospital leading the study, CTU-HUVR, and is responsible for the whole coordination of the study and all the sites involved, submitting the administrative authorizations of the study, handling regulatory affairs, contact with ethics committees and response, drug management, labeling and distribution of the IMPs, safety monitoringand pharmacovigilance responsibilities of the sponsor, as well as logistic coordination and providing a contact point for all the 32 clinical teams participating in the study and monitoring activities.